Yumanity Therapeutics is a clinical-stage biopharmaceutical company that is accelerating the revolution in the treatment of neurodegenerative diseases through its transformative scientific foundation and drug discovery platform.
Yumanity Therapeutics contracted Wakefly to plan, design and implement their new website in a very short timeframe that coincided with a reverse merger. Wakefly and the Yumanity team worked closely over the period of about two weeks in order to be live for their merger announcement on the NASDQ composite.
